In vivo eradication of Friend virus as an experimental HIV-model, by combination of zidovudine, acriflavine and an ellipticine analogue. Possible application to the treatment of human pre-AIDS?

This publication has 16 references indexed in Scilit:

• Preliminary analysis of the Concorde trial
  The Lancet, 1993
• Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy
  Nature, 1993
• The in vivo effect of ellipticine analogues on the blood concentration of Friend virus: a murine model for studying anti-HIV drugs
  Biomedicine & Pharmacotherapy, 1993
• A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1992
• Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group
  Blood, 1991
• Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1990
• Amino acridines action on Friend's retrovirus in relation to their molecular ionization
  Biomedicine & Pharmacotherapy, 1989
• Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy
  AIDS, 1989
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987